Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2026-08-11

FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA supplemental approval for Glipizide and Metformin hydrochloride combination product (Zydus Pharmaceuticals USA Inc.).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide and Metformin Hydrochloride (glipizide and metformin hydrochloride)

Snippet

SUPPL AP for GLIPIZIDE AND METFORMIN HYDROCHLORIDE (GLIPIZIDE AND METFORMIN HYDROCHLORIDE)